Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer

Systemic treatment for triple negative breast cancer (TNBC: negative for the expression of estrogen receptor and progesterone receptor and HER2 amplification) has been limited to chemotherapy options. Neoadjuvant chemotherapy induces tumor shrinkage and improves the surgical outcomes of patients wit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ademuyiwa, Foluso O., Ellis, Matthew J., Ma, Cynthia X.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747378/
https://ncbi.nlm.nih.gov/pubmed/23983689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/219869
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares